Table 1 summarizes key studies on ACTL6A across various cancer types, highlighting its role as an oncogene and its involvement in tumor progression, metastasis, and poor prognosis in liver, squamous cell carcinoma, breast, glioblastoma, gastric, colorectal, ovarian, cervical, and other malignancies. The gene discussed is ACTL6A; the disease is glioblastoma.